We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
+13.69%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$2.85B
AUM Growth
+$268M
Cap. Flow
-$44.9M
Cap. Flow %
-1.57%
Top 10 Hldgs %
16.28%
Holding
448
New
36
Increased
128
Reduced
236
Closed
29

Top Sells

Rank Stock Value
1
PSN icon
Parsons
PSN
+$16.9M
2
FN icon
Fabrinet
FN
+$16M
3
PXD
Pioneer Natural Resource Co.
PXD
+$10.6M
4
MAS icon
Masco
MAS
+$9.31M
5
AAPL icon
Apple
AAPL
+$8.74M

Sector Composition

Rank Sector Weight
1 Technology 21.98%
2 Financials 15.97%
3 Healthcare 11.39%
4 Industrials 11.23%
5 Consumer Discretionary 9.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INSP icon
376
Inspire Medical Systems
INSP
$1.76B
$762K 0.03%
3,748
-1,680
-31% -$272K
INSM icon
377
Insmed
INSM
$28.8B
$744K 0.03%
23,999
+10,338
+76% +$268K
NVTS icon
378
Navitas Semiconductor
NVTS
$3.62B
$721K 0.03%
89,369
-12,077
-12% -$81K
HEES
379
DELISTED
H&E Equipment Services
HEES
$698K 0.02%
13,343
-1,800
-12% -$81.3K
PVH icon
380
PVH
PVH
$3.99B
$696K 0.02%
+5,701
New +$510K
FTNT icon
381
Fortinet
FTNT
$122B
$691K 0.02%
11,798
+2,056
+21% +$114K
ARGX icon
382
argenx
ARGX
$55.2B
$682K 0.02%
1,792
+208
+13% +$96.9K
AEO icon
383
American Eagle Outfitters
AEO
$2.98B
$669K 0.02%
+31,605
New +$589K
IONS icon
384
Ionis Pharmaceuticals
IONS
$9.39B
$657K 0.02%
+12,982
New +$622K
ARRY icon
385
Array Technologies
ARRY
$830M
$646K 0.02%
38,451
-13,088
-25% -$226K
CECO icon
386
Ceco Environmental
CECO
$4.17B
$637K 0.02%
31,438
+11,570
+58% +$211K
IVV icon
387
iShares Core S&P 500 ETF
IVV
$906B
$614K 0.02%
1,286
AVAV icon
388
AeroVironment
AVAV
$9.4B
$593K 0.02%
+4,704
New +$575K
ANIP icon
389
ANI Pharmaceuticals
ANIP
$1.72B
$578K 0.02%
10,472
+4,641
+80% +$256K
ONTO icon
390
Onto Innovation
ONTO
$15.1B
$563K 0.02%
3,676
-498
-12% -$67K
ARHS icon
391
Arhaus
ARHS
$1.37B
$559K 0.02%
47,101
-35,507
-43% -$335K
WOLF icon
392
Wolfspeed
WOLF
$1.64B
$550K 0.02%
+12,649
New +$459K
SWKS icon
393
Skyworks Solutions
SWKS
$10.5B
$533K 0.02%
4,739
+858
+22% +$84K
ALGN icon
394
Align Technology
ALGN
$12.4B
$517K 0.02%
1,886
+342
+22% +$81.1K
BHVN icon
395
Biohaven
BHVN
$2.21B
$504K 0.02%
11,780
-12,780
-52% -$397K
GDYN icon
396
Grid Dynamics Holdings
GDYN
$617M
$488K 0.02%
36,656
-4,949
-12% -$60.3K
DAR icon
397
Darling Ingredients
DAR
$9.87B
$486K 0.02%
9,761
-1,053
-10% -$47.8K
DVN icon
398
Devon Energy
DVN
$49.2B
$483K 0.02%
10,662
+1,923
+22% +$88K
FUSN
399
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$480K 0.02%
+49,890
New +$242K
WFRD icon
400
Weatherford International
WFRD
$6.47B
$472K 0.02%
+4,830
New +$449K

Similar funds

Chartwell Investment Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Chartwell Investment Partners held 448 positions worth $2.85B, up 10% from $2.58B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Chartwell Investment Partners's Q4 2023 filing shows 36 new, 128 increased, 236 reduced and 29 closed positions. Its largest new stake was Applied Materials: 47,430 shares worth $7.69M. The largest sale was Parsons, an estimated $16.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

  • Chartwell Investment Partners's largest Q4 2023 buy was Applied Materials: 47,430 shares worth $7.69M.
  • Chartwell Investment Partners added most to Diamondback Energy in Q4 2023, an estimated $9.67M increase.
  • Chartwell Investment Partners's biggest Q4 2023 reduction was Fabrinet, cutting an estimated $16M.
  • Chartwell Investment Partners fully exited Parsons in Q4 2023, selling an estimated $16.9M.
  • Chartwell Investment Partners's ten largest holdings make up 16% of its $2.85B portfolio in Q4 2023.
  • Chartwell Investment Partners opened 36 new positions and closed 29 in Q4 2023.
  • Chartwell Investment Partners's portfolio value rose 10% quarter-over-quarter to $2.85B.

Based on Chartwell Investment Partners's 13F filing for Q4 2023, filed 15 Feb 2024.